Monarch Partners Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,760
Closed -$223K 200
2016
Q4
$223K Hold
11,760
0.02% 168
2016
Q3
$263K Buy
+11,760
New +$263K 0.02% 157